Vaccine for cervical cancer prevention to be available in small quantity in 2023, increased next year, says Adar Poonawalla, Health News, ET HealthWorld

File Photo New Delhi: A day after the launch of the first made-in-India Human Papillomavirus (HPV) “CERVAVAC” vaccine for the prevention of cervical cancer, Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday said that the availability of the vaccine will be little in number this year, however, it would be boosted next year. Poonawalla briefed Union Health Minister Mansukh Mandaviya about the HPV vaccine in the national capital.Speaking to after the meeting, the SII CEO said, “I had come to brief the Union Health minister…

Read More

Union Budget 2023-24: Will Communicable Diseases be one of the Focal Points?, Health News, ET HealthWorld

By Ritika Sakhuja and Prathiba Raju New Delhi: Communicable diseases pose a substantial challenge to the public health system in India. With increased public spending on healthcare more attention is the need of the hour, inform domain experts. The emergence of new COVID strains, increasing cases of measles and tuberculosis (TB), Zika virus and Japanese Encephalitis (JE) in various parts of India, highlight the need for increased budgetary spending to strengthen the healthcare industry’s response to communicable diseases. Moreover, The Ministry of Health and Family Welfare’s (MoHFW) goal of making…

Read More

Booster dose of Covishield offers best immune response: Lancet study, Health News, ET HealthWorld

New Delhi: A booster dose of Covishield offers the best immune response, irrespective of whether the primary doses were of Covishield or Covaxin, according to a new study conducted in India and published in The Lancet Regional Health Southeast Asia journal. According to the study, even though homologous and heterologous boosting with Covishield or Covaxin in Covishield or Covaxin primed individuals are immunogenic and safe, boosting with Covishield produced better binding and functional antibodies, irrespective of whether the primary vaccination series used Covishield or Covaxin. Primary SARS-CoV-2 vaccination has been…

Read More

Sun Pharmaceutical launches phenobarbital sodium injection in US, Health News, ET HealthWorld

New Delhi: Sun Pharmaceutical Industries Ltd on Wednesday launched its phenobarbital sodium injection, SEZABY for the treatment of neonatal seizures in the US. SEZABY is the first and only product approved by the US Food and Drug Administration (USFDA) for the treatment of neonatal seizures in term and preterm infants, Sun Pharma said in a regulatory filing. It is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection. “The launch of SEZABY is an exciting addition to our growing portfolio of specialty branded products in the…

Read More

Paracetamol maker Granules India posts 23 per cent rise in Q3 profit, Health News, ET HealthWorld

Bengaluru: Pharmaceutical company Granules India Ltd, reported a 23 per cent rise in third-quarter profit on Tuesday, propelled by strong demand for the painkiller drug Paracetamol. Consolidated profit rose to 1.24 billion rupees ($15.22 million) for the three months ended Dec. 31, from 1.01 billion rupees a year earlier. Consolidated revenue for the company rose nearly 15 per cent to 11.46 billion rupees, “primarily driven by higher Paracetamol API sales in the US,” the company said in an exchange filing. “Opportunities in Paracetamol are likely to continue and our geography…

Read More

Covid Drug: New oral antiviral drug likely to get Centre’s approval for treating Covid, Health News, ET HealthWorld

Pune: The Union health ministry is likely to include an oral antiviral drug, nirmatrelvir-ritonavir combination, in the country’s upcoming Covid treatment protocol for patients with mild to moderate disease, who are at high risk of developing severe illness. The combination drug, popularly known by the brand name paxlovid, is currently in high demand in China and a few other nations battling the Covid surge. India’s upcoming Covid treatment protocol is expected to be released within a week. “The combination two-tablet oral drug therapy is likely to be recommended in India…

Read More

Amazon launches a subscription prescription drug service, Health News, ET HealthWorld

New Delhi: Amazon is adding a prescription drug discount program to its growing health care business. The retail giant said Tuesday that it will launch RxPass, a subscription service for customers who have Prime memberships. Amazon said people will pay $5 a month to fill as many prescriptions as they need from a list of about 50 generic medications, which are generally cheaper versions of brand-name drugs. The company said the flat fee could cover a list of medications like the antibiotic amoxicillin and the anti-inflammatory drug naproxen. Sildenafil also…

Read More

WHO investigating links among cough syrup deaths, considers advice for parents, Health News, ET HealthWorld

New Delhi: The World Health Organization (WHO) is investigating whether there is any connection between manufacturers whose contaminated cough syrups it has linked to the deaths of more than 300 children in three countries. Citing “unacceptable levels” of toxins in the products, the WHO is seeking more information about the specific raw materials used by six manufacturers in India and Indonesia to produce medicines linked to the recent deaths, as well as whether the companies obtained them from some of the same suppliers, the person said. The WHO has not…

Read More

India can have its own model for emergency response for other countries to emulate: Mandaviya, Health News, ET HealthWorld

New Delhi: Highlighting that India’s disaster management model has potential to go beyond the standard operating procedures (SOPs) to be flexible and agile to deal with exigencies on the ground, Dr Mansukh Mandaviya, Union Minister for Health and Family Welfare on Tuesday said, “Being a vast country with diverse terrains and geographies, India can have its own model for disaster or emergency response which can be emulated by other countries.” Addressing the consultative workshop on the National Emergency Medical Team (NEMT) India, Mandaviya said, “While it is important to learn…

Read More